AI News NQ Analysis

[Fullhope Biotech] Announcement of Full Board of Directors Reshuffle at 115th Annual General Meeting of Shareholders

NQ Score 85/100
N1 Content Completeness 10

AI Summary (NQ-processed)

Fullhope Biotech Inc. has announced a full reshuffle of its board of directors at the 115th Annual General Meeting of Shareholders. The reshuffle includes 9 directors, comprising natural person directors, corporate directors, and independent directors, with more than one-third of the directors being changed.

AI Analysis

Frequently Asked Questions

Q: When was the board of directors reshuffle at Fullhope Biotech Inc. held?
A: The board of directors reshuffle at Fullhope Biotech Inc. was held on June 12, 2026.
Q: Which positions are included in this board of directors reshuffle?
A: This board of directors reshuffle includes natural person directors, corporate directors, and independent directors, totaling 9 people.
Q: Who is included in the new directors?
A: The new directors include Lin Qun, Xu Wenqi, Guo Meihui, Zhang Zhenwu, Wei Yongdu, Anfuda Health One Limited Partnership, and independent directors Guo Zongming, Cheng Shouzhen, and Li Zhongxi.
Q: What is the reason for this board of directors reshuffle?
A: The reason for this board of directors reshuffle is the shareholder meeting election, as the term of the former directors has expired.
Q: What is the number of shares held by the new directors at the time of their appointment?
A: The number of shares held by the new directors at the time of their appointment is 930,000 shares for Lin Qun, 340,000 shares for Xu Wenqi, 296,189 shares for Guo Meihui, 0 shares for Zhang Zhenwu, 0 shares for Wei Yongdu, 12,000,000 shares for Anfuda Health One Limited Partnership, and 0 shares for independent directors Guo Zongming, Cheng Shouzhen, and Li Zhongxi.